211 related articles for article (PubMed ID: 25081539)
1. Low expression of CD112 is associated with poor overall survival in patients with hepatocellular carcinoma.
Huang X; Qu P; Chen Y; Zhou X; Wu Y; Liu F; Wang D; Zhang J; An J
Hum Pathol; 2014 Sep; 45(9):1944-50. PubMed ID: 25081539
[TBL] [Abstract][Full Text] [Related]
2. Expression and prognostic significance of vascular endothelial growth factor receptor 1 in hepatocellular carcinoma.
Li T; Zhu Y; Qin CY; Yang Z; Fang A; Xu S; Ren W
J Clin Pathol; 2012 Sep; 65(9):808-14. PubMed ID: 22734007
[TBL] [Abstract][Full Text] [Related]
3. A low level of GPR37 is associated with human hepatocellular carcinoma progression and poor patient survival.
Liu F; Zhu C; Huang X; Cai J; Wang H; Wang X; He S; Liu C; Yang X; Zhang Y; Zhang T
Pathol Res Pract; 2014 Dec; 210(12):885-92. PubMed ID: 25169131
[TBL] [Abstract][Full Text] [Related]
4. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W
Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469
[TBL] [Abstract][Full Text] [Related]
5. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
[TBL] [Abstract][Full Text] [Related]
6. High expression of trimethylated histone H3 lysine 4 is associated with poor prognosis in hepatocellular carcinoma.
He C; Xu J; Zhang J; Xie D; Ye H; Xiao Z; Cai M; Xu K; Zeng Y; Li H; Wang J
Hum Pathol; 2012 Sep; 43(9):1425-35. PubMed ID: 22406368
[TBL] [Abstract][Full Text] [Related]
7. Reduced N-cadherin expression is associated with metastatic potential and poor surgical outcomes of hepatocellular carcinoma.
Zhan DQ; Wei S; Liu C; Liang BY; Ji GB; Chen XP; Xiong M; Huang ZY
J Gastroenterol Hepatol; 2012 Jan; 27(1):173-80. PubMed ID: 21777276
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-224 upregulation and AKT activation synergistically predict poor prognosis in patients with hepatocellular carcinoma.
Yu L; Zhang J; Guo X; Li Z; Zhang P
Cancer Epidemiol; 2014 Aug; 38(4):408-13. PubMed ID: 24923856
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma.
Cui X; Hu ZP; Li Z; Gao PJ; Zhu JY
World J Gastroenterol; 2015 Jul; 21(28):8588-604. PubMed ID: 26229401
[TBL] [Abstract][Full Text] [Related]
10. CC chemokine receptor 6 expression predicts poor prognosis in hepatocellular carcinoma.
Liu F; Lv H; Jia X; Liu G; Li T; Xu Z; Li J
J Surg Oncol; 2014 Aug; 110(2):151-5. PubMed ID: 24634224
[TBL] [Abstract][Full Text] [Related]
11. Elevated expression of DKK1 is associated with cytoplasmic/nuclear beta-catenin accumulation and poor prognosis in hepatocellular carcinomas.
Yu B; Yang X; Xu Y; Yao G; Shu H; Lin B; Hood L; Wang H; Yang S; Gu J; Fan J; Qin W
J Hepatol; 2009 May; 50(5):948-57. PubMed ID: 19303159
[TBL] [Abstract][Full Text] [Related]
12. Low expression of DAB2IP contributes to malignant development and poor prognosis in hepatocellular carcinoma.
Zhang X; Li N; Li X; Zhao W; Qiao Y; Liang L; Ding Y
J Gastroenterol Hepatol; 2012 Jun; 27(6):1117-25. PubMed ID: 22168621
[TBL] [Abstract][Full Text] [Related]
13. Identification of intragenic methylation in the TUSC1 gene as a novel prognostic marker of hepatocellular carcinoma.
Shimizu D; Kanda M; Nomoto S; Oya H; Takami H; Hibino S; Suenaga M; Inokawa Y; Hishida M; Takano N; Nishikawa Y; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Oncol Rep; 2014 Mar; 31(3):1305-13. PubMed ID: 24366000
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor binding protein-1 inhibits cancer cell invasion and is associated with poor prognosis in hepatocellular carcinoma.
Dai B; Ruan B; Wu J; Wang J; Shang R; Sun W; Li X; Dou K; Wang D; Li Y
Int J Clin Exp Pathol; 2014; 7(9):5645-54. PubMed ID: 25337205
[TBL] [Abstract][Full Text] [Related]
15. [Expression of PCAF in hepatocellular carcinoma and its clinical significance].
Tuo H; Zheng X; Tu K; Zhou Z; Yao Y; Liu Q
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Mar; 29(3):297-300. PubMed ID: 23643089
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of XPO4 is associated with poor prognosis in hepatocellular carcinoma.
Liang XT; Pan K; Chen MS; Li JJ; Wang H; Zhao JJ; Sun JC; Chen YB; Ma HQ; Wang QJ; Xia JC
J Gastroenterol Hepatol; 2011 Mar; 26(3):544-9. PubMed ID: 21332550
[TBL] [Abstract][Full Text] [Related]
17. CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery.
Yang XR; Xu Y; Yu B; Zhou J; Li JC; Qiu SJ; Shi YH; Wang XY; Dai Z; Shi GM; Wu B; Wu LM; Yang GH; Zhang BH; Qin WX; Fan J
Clin Cancer Res; 2009 Sep; 15(17):5518-27. PubMed ID: 19706825
[TBL] [Abstract][Full Text] [Related]
18. Cytokeratin 10 and cytokeratin 19: predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resection.
Yang XR; Xu Y; Shi GM; Fan J; Zhou J; Ji Y; Sun HC; Qiu SJ; Yu B; Gao Q; He YZ; Qin WZ; Chen RX; Yang GH; Wu B; Lu Q; Wu ZQ; Tang ZY
Clin Cancer Res; 2008 Jun; 14(12):3850-9. PubMed ID: 18559605
[TBL] [Abstract][Full Text] [Related]
19. [Expression of CD112 in colon carcinoma tissues and cell lines and their clinical significance].
Wang HT; Zhang Z; Fan M; Wang L; Dong GL
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 May; 26(5):477-9. PubMed ID: 20617580
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of ZBP-89 and its prognostic significance in hepatocellular carcinoma.
Zhang CZ; Cao Y; Yun JP; Chen GG; Lai PB
Histopathology; 2012 Jun; 60(7):1114-24. PubMed ID: 22372401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]